These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34594933)

  • 41. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria.
    Adejumo OA; Olusola-Faleye B; Adepoju V; Bowale A; Adesola S; Falana A; Owuna H; Otemuyiwa K; Oladega S; Adegboye O
    Afr Health Sci; 2018 Sep; 18(3):472-478. PubMed ID: 30602977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of
    Li Y; Zhao A; Yu Q; Yu N; Cui Y; Ma X; Liu H; Wang R
    Microbiol Spectr; 2023 Aug; 11(4):e0094423. PubMed ID: 37306591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda.
    Izudi J; Tamwesigire IK; Bajunirwe F
    J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100153. PubMed ID: 32123755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
    Tahseen S; Khanzada FM; Rizvi AH; Qadir M; Ghazal A; Baloch AQ; Mustafa T
    PLoS One; 2020; 15(9):e0239328. PubMed ID: 32966321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
    Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
    Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China.
    Zhang SJ; Yang Y; Sun WW; Zhang ZS; Xiao HP; Li YP; Zhang ZM; Fan L
    BMC Infect Dis; 2022 Aug; 22(1):715. PubMed ID: 36038829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment cascade for patients with multidrug- or rifampicin-resistant tuberculosis and associated factors with patient attrition in southeastern China: a retrospective cohort study.
    Chen B; Chen X; Ren Y; Peng Y; Wang F; Zhou L; Xu B
    J Infect Public Health; 2023 Jul; 16(7):1073-1080. PubMed ID: 37209611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Tuberculosis Outbreak During the COVID-19 Pandemic - Hubei Province, China, 2020.
    Li D; Peng X; Hou S; Li T; Yu XJ
    China CDC Wkly; 2021 Jun; 3(26):562-565. PubMed ID: 34594936
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities.
    Howell P; Achar J; Huang GKL; Mariandyshev A; Schaaf HS; Garcia-Prats AJ
    Pathogens; 2022 Mar; 11(4):. PubMed ID: 35456056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015-2018: A retrospective study.
    Xu Y; Li Q; Zhu M; Wu X; Wang D; Luo J; Li Y; Zhong J; Zeng P
    Medicine (Baltimore); 2020 Oct; 99(43):e22608. PubMed ID: 33120748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
    PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.
    Timire C; Metcalfe JZ; Chirenda J; Scholten JN; Manyame-Murwira B; Ngwenya M; Matambo R; Charambira K; Mutunzi H; Kalisvaart N; Sandy C
    Int J Infect Dis; 2019 Oct; 87():119-125. PubMed ID: 31357057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rifampicin resistance conferring mutations among
    Cuella-Martin I; Semuto Ngabonziza JC; Torrea G; Meehan CJ; Mulders W; Ushizimpumu B; De Weerdt L; Keysers J; De Rijk WB; Decroo T; De Jong BC; Rigouts L
    Int J Mycobacteriol; 2023; 12(3):274-281. PubMed ID: 37721232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender-Specific Association Between Perceived Stigma Toward Tuberculosis and Acceptance of Preventive Treatment Among College Students With Latent Tuberculosis Infection: Cross-Sectional Analysis.
    Yuan Y; Jin J; Bi X; Geng H; Li S; Zhou C
    JMIR Public Health Surveill; 2023 Jun; 9():e43972. PubMed ID: 37314847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiplex LNA probe-based RAP assay for rapid and highly sensitive detection of rifampicin-resistant
    Zhang R; Ou X; Sun X; Fan G; Zhao B; Tian F; Li F; Shen X; Zhao Y; Ma X
    Front Microbiol; 2023; 14():1141424. PubMed ID: 37180280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.